Dicerna Pharmaceuticals, Inc.
USD38.22
+0.00 (+0.00%)
CEO
Douglas Fambrough
IPO Date
2014-01-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$38.21
Prev. Close
$38.22
Day Low
$38.21
Day High
$38.24
52W Low
$19.06
52W High
$40.14
Volume
5.54M
| -12.5 |
| 31 Dec 2018 | FY | 100.0% | -1438.7% | -44.3% | -21.7% | 0.00 | 4.31 | -6.7 |
| 31 Dec 2017 | FY | 100.0% | -2637.2% | -59.3% | -49.7% | 0.00 | 7.12 | -3.1 |
| 31 Dec 2016 | FY | 100.0% | -20173.9% | -144.4% | -116.1% | 0.00 | 4.76 | -1.0 |
| 31 Dec 2015 | FY | 100.0% | -34151.6% | -69.0% | -62.8% | 0.00 | 10.68 | -3.8 |
| 31 Dec 2014 | FY | 0.0% | 0.0% | -48.7% | -46.3% | 0.00 | 18.86 | -5.5 |
| 31 Dec 2013 | FY | 0.0% | 0.0% | 26.9% | -37.2% | -0.07 | 6.34 | -41.3 |
| 31 Dec 2012 | FY | 100.0% | -144.3% | 15.6% | -99.3% | -0.14 | 1.59 | -9.3 |
| 31 Dec 2011 | FY | 100.0% | -108.2% | 16.9% | -34.7% | -0.23 | 4.34 | -418.9 |
| -17.6 |
| 31 Mar 2021 | Q1 | 100.0% | -62.9% | -23.7% | -4.4% | 0.41 | 3.26 | -16.3 |
| 31 Dec 2020 | Q4 | 100.0% | -89.3% | -26.6% | -5.2% | 0.38 | 3.48 | -11.2 |
| 30 Sept 2020 | Q3 | 100.0% | -44.7% | -14.2% | -3.2% | 0.14 | 2.62 | -15.3 |
| 30 Jun 2020 | Q2 | 100.0% | -78.7% | -19.6% | -4.3% | 0.14 | 2.63 | -14.8 |
| 31 Mar 2020 | Q1 | 100.0% | -66.1% | -12.6% | -2.9% | 0.13 | 2.90 | -14.9 |
| 31 Dec 2019 | Q4 | 100.0% | -560.3% | -26.1% | -6.6% | 0.15 | 2.30 | -9.5 |
| 30 Sept 2019 | Q3 | 100.0% | -383.2% | -22.9% | -9.2% | 0.02 | 2.68 | -8.0 |
| 30 Jun 2019 | Q2 | 100.0% | -419.7% | -14.9% | -6.6% | 0.02 | 3.65 | -11.2 |